José Luis Leal

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

European Cardiovascular Disease Statistics 2017

Elizabeth Wilkins, Lloyd R. Wilson, Kremlin Wickramasinghe et al. · Bristol Research (University of Bristol) · 2017 · 522 citations

Medicine, Cardiology, Clinical Cardiology +10

European Cardiovascular Disease Statistics 2012

Melanie Nichols, Nick Townsend, Ramón Luengo-Fernández et al. · Bristol Research (University of Bristol) · 2012 · 380 citations

Medicine, Cardiology, Clinical Cardiology +10

EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non–Small Cell Lung Cancer

José Luis Leal, Marliese Alexander, Malinda Itchins et al. · Clinical Lung Cancer · 2021 · 37 citations

Medicine, Molecular Genetics, Oncology +16

NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer

José Luis Leal, Geoffrey Peters, Marcin Szaumkessel et al. · Lung Cancer · 2020 · 34 citations

Medicine, Oncology, Pathology +15